IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
INCIDENCE AND ASSOCIATED FACTORS OF ADVERSE DRUG REACTIONS IN GENERAL MEDICINE DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL

Author: RACHANA J, C.S. SHASTRY, UDAY VENKAT MATETI, RAGHAV SHARMA, NANDAKUMAR UP, SHARAD CHAND
Abstract: Adverse drug reactions (ADRs) are one of the major causes of morbidity and mortality. To assess the incidence and cost involved in ADRs reported in the general medicine department. A prospective observational study was carried out for a period of 8 months from August 2016 to March 2017. Patients enrolled as per the study criteria then ADRs data was evaluated by assessment of causality, severity, and preventability. The cost incurred for the management of ADRs was calculated. From a total number of 240 patients, 127 (52.91%) were males and 113 (47.08%) were females. The causality assessment by Naranjo’s scale showed that the majority of the reactions was probable 32 (72.7%), followed by possible 12 (27.3%). Based on WHO-UMC Scale, 36 (81.8%) were probable, followed by 8(18.2%) possible reactions. Majority of the reactions, 29 (66%) were moderate in severity. About 42 (95.5%) reactions were probably preventable, and 2 (4.5%) were preventable. Total cost for the management of ADRs was INR 173673.00. The study concludes that regular monitoring of ADRs may be required to reduce the morbidity and to improve patient compliance, which in turn can produce a better therapeutic outcome.
Keyword: Adverse Drug Reaction, Causality Assessment, Incidence, General Medicine
DOI: https://doi.org/10.31838/ijpr/2019.11.03.027
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477